Position: Deputy Director
Professional Title: Chief Physician
Specialties: Diagnosis and treatment of various thoracic tumors (including lung cancer, thymic tumors, pleural mesothelioma, etc.)
Representative Achievements:
Research Project: Study on the Function and Mechanism of HDGF‑mediated CAFs in Promoting the Maintenance of NSCLC Cancer Stem Cells in Chemotherapy Resistance. General Program of National Natural Science Foundation of China
Publications:
- Prevalence, genetic variations and clinical outcomes of BRAF‑V600 mutated advanced NSCLC in China: a retrospective real‑world multi‑centre study. EBioMedicine 2025 Apr:114:105652. doi: 10.1016. Corresponding Author
- Efficacy and safety of first‑line chemoimmunotherapy in young patients with extensive‑stage small cell lung cancer: a multicenter retrospective study. BMC Cancer volume 25, Article number: 1136 (2025). Co‑corresponding Author
- High‑dose hyperfractionated simultaneous integrated boost radiotherapy versus standard‑dose radiotherapy for limited‑stage small‑cell lung cancer in China: a multicentre, open‑label, randomised, phase 3 trial. Lancet Respir Med. 2024 Oct;12(10):799‑809. Corresponding Author
- Anlotinib hydrochloride consolidation after concurrent chemoradiotherapy in stage III non‑small‑cell lung cancer: a truncated, randomized, multicenter, clinical study (ALTER‑L029) Anticancer Drugs. 2024 Aug 1;35(7):680‑685. Corresponding Author
- First‑line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive‑stage small‑cell lung cancer. BMC Cancer. 2023; 23: 318. Corresponding Author
Science and Technology Awards:
First Prize for Science and Technology Progress of the Ministry of Education (2019): Establishment and Clinical Promotion of Lung Cancer Individualized Diagnosis and Treatment System Based on Peripheral Blood Molecular Subtyping (Fourth Completion Author)
English